Grantham, Mayo, Van Otterloo & Co (GMO)’s PRA Health Sciences, Inc. PRAH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-507,891	Closed	-$77.9M	–	893
2021 Q1	$77.9M	Buy	+507,891	New	+$69M	0.43%	49
2018 Q3	–	Sell	-8,200	Closed	-$766K	–	611
2018 Q2	$766K	Hold	8,200	–	–	0.01%	402
2018 Q1	$680K	Hold	8,200	–	–	﹤0.01%	422
2017 Q4	$747K	Buy	8,200 +4,100	+100%	+$341K	﹤0.01%	383
2017 Q3	$312K	Hold	4,100	–	–	﹤0.01%	472
2017 Q2	$308K	Buy	4,100 +300	+8%	+$20.8K	﹤0.01%	465
2017 Q1	$248K	Buy	+3,800	New	+$224K	﹤0.01%	467

Other funds holding PRAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PRAH Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 507,891 shares — an estimated $77.9M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PRAH in Q1 2017 and held it in 7 quarters. The position peaked at $77.9M in Q1 2021. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 507,891 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $77.9M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s PRA Health Sciences, Inc. position peaked at $77.9M in Q1 2021.
317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.